Total Funding
39
61
Total FundingSeries B raised
Growth Score
-7 pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
47803
Cadence Neuroscience is an early-stage company developing medical device therapies for epilepsy.
- Kent Leyde: Co-Founder and Chief Executive OfficePast Role: Ventec Life Systems, Vice President of Engineering
- Doug Sheffield: CSO
About the Company
Cadence Neuroscience is an early-stage company developing new medical device therapies for the treatment of epilepsy, central pain, and other neurological disorders. The company's core technology has been developed at Mayo Clinic and is under clinical evaluation. Its medical device therapies provide medical practitioners with a procedure that
can be used to tailor brain stimulation therapy to each individual and enhance seizure control compared to currently used protocols.
Cadence Neuroscience was established in 2017 and is headquartered in Redmond, Washington.
